{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T02:03:43Z","timestamp":1790561023941,"version":"4.1.0"},"reference-count":248,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009004","name":"Anhui University of Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009004","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.phrs.2023.106925","type":"journal-article","created":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T22:18:42Z","timestamp":1694643522000},"page":"106925","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"special_numbering":"C","title":["Natural products in non-alcoholic fatty liver disease (NAFLD): Novel lead discovery for drug development"],"prefix":"10.1016","volume":"196","author":[{"given":"Lu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghuan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linfang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.phrs.2023.106925_bib1","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/hep.32743","article-title":"Health disparities in chronic liver disease","volume":"77","author":"Kardashian","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2023.106925_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101833","article-title":"Emerging role of aging in the progression of NAFLD to HCC","volume":"84","author":"He","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"2","key":"10.1016\/j.phrs.2023.106925_bib3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jhep.2023.03.040","article-title":"Global incidence of non-alcoholic fatty liver disease: a systematic review and meta-analysis of 63 studies and 1,201,807 persons","volume":"79","author":"Le","year":"2023","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.phrs.2023.106925_bib4","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030","volume":"69","author":"Estes","year":"2018","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.phrs.2023.106925_bib5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jhep.2021.05.022","article-title":"Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: Data from global burden of disease 2009-2019","volume":"75","author":"Golabi","year":"2021","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.phrs.2023.106925_bib6","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.31150","article-title":"Epidemiological Features of NAFLD From 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.phrs.2023.106925_bib7","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.phrs.2023.106925_bib8","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/hep.32542","article-title":"NAFLD-related hepatocellular carcinoma: the growing challenge","volume":"77","author":"Shah","year":"2023","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.phrs.2023.106925_bib9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.mcna.2022.12.003","article-title":"Nonalcoholic fatty liver disease: a unique entity or part of the metabolic syndrome or both","volume":"107","author":"Yip","year":"2023","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.phrs.2023.106925_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.semcancer.2023.03.008","article-title":"Excess body weight: Novel insights into its roles in obesity comorbidities","volume":"92","author":"Zhang","year":"2023","journal-title":"Semin. Cancer Biol."},{"issue":"7","key":"10.1016\/j.phrs.2023.106925_bib11","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S2468-1253(21)00020-0","article-title":"Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach","volume":"6","author":"Targher","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106925_bib12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S2468-1253(20)30294-6","article-title":"Redefining fatty liver disease: an international patient perspective","volume":"6","author":"Shiha","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.phrs.2023.106925_bib13","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/hep.31518","article-title":"Multiple parallel hits hypothesis in nonalcoholic fatty liver disease: revisited after a decade","volume":"73","author":"Tilg","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2023.106925_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00109-022-02282-4","article-title":"Recent updates on targeting the molecular mediators of NAFLD","volume":"101","author":"Wang","year":"2023","journal-title":"J. Mol. Med."},{"issue":"6","key":"10.1016\/j.phrs.2023.106925_bib15","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1002\/hep.32081","article-title":"Multidisciplinary clinic models: a paradigm of care for management of NAFLD","volume":"74","author":"Kumar","year":"2021","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.phrs.2023.106925_bib16","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1080\/14740338.2017.1343299","article-title":"Treatment options for nonalcoholic steatohepatitis-a safety evaluation","volume":"16","author":"Issa","year":"2017","journal-title":"Expert Opin. Drug Saf."},{"issue":"1","key":"10.1016\/j.phrs.2023.106925_bib17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1517\/13543784.14.1.29","article-title":"Recent advances in the treatment of non-alcoholic fatty liver disease","volume":"14","author":"Mendes","year":"2005","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"5","key":"10.1016\/j.phrs.2023.106925_bib18","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1002\/hep.31599","article-title":"NAFLD: reporting histologic findings in clinical practice","volume":"73","author":"Brunt","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.phrs.2023.106925_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1210\/endrev\/bnz009","article-title":"Nonalcoholic fatty liver disease in adults: current concepts in etiology, outcomes, and management","volume":"41","author":"Marjot","year":"2020","journal-title":"Endocr. Rev."},{"issue":"8","key":"10.1016\/j.phrs.2023.106925_bib20","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.biotechadv.2015.08.001","article-title":"Discovery and resupply of pharmacologically active plant-derived natural products: A review","volume":"33","author":"Atanasov","year":"2015","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.phrs.2023.106925_bib21","doi-asserted-by":"crossref","first-page":"5276130","DOI":"10.1155\/2016\/5276130","article-title":"Role of antioxidants and natural products in inflammation","volume":"2016","author":"Arulselvan","year":"2016","journal-title":"Oxid. Med. Cell Longev."},{"issue":"8","key":"10.1016\/j.phrs.2023.106925_bib22","doi-asserted-by":"crossref","first-page":"12581","DOI":"10.1002\/jcp.28134","article-title":"Dietary natural products as emerging lipoprotein(a)-lowering agents","volume":"234","author":"Momtazi-Borojeni","year":"2019","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.phrs.2023.106925_bib23","doi-asserted-by":"crossref","first-page":"8820406","DOI":"10.1155\/2021\/8820406","article-title":"Natural products for neurodegeneration: regulating neurotrophic signals","volume":"2021","author":"Uddin","year":"2021","journal-title":"Oxid. Med. Cell Longev."},{"issue":"17","key":"10.1016\/j.phrs.2023.106925_bib24","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.3390\/nu14173459","article-title":"Berberine in non-alcoholic fatty liver disease-a review","volume":"14","author":"Koperska","year":"2022","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.phrs.2023.106925_bib25","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/liv.13562","article-title":"Ursodeoxycholic acid: effects on hepatic unfolded protein response, apoptosis and oxidative stress in morbidly obese patients","volume":"38","author":"Mueller","year":"2018","journal-title":"Liver Int"},{"issue":"12","key":"10.1016\/j.phrs.2023.106925_bib26","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.cgh.2017.04.016","article-title":"A randomized trial of silymarin for the treatment of nonalcoholic steatohepatitis","volume":"15","author":"Wah Kheong","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106925_bib27","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41392-022-01119-3","article-title":"Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver\/steatohepatitis (NAFL\/NASH)","volume":"7","author":"Xu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.phrs.2023.106925_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107686","article-title":"The strategies and techniques of drug discovery from natural products","volume":"216","author":"Zhang","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.phrs.2023.106925_bib29","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41575-021-00502-9","article-title":"Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests","volume":"18","author":"Masoodi","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"17","key":"10.1016\/j.phrs.2023.106925_bib30","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2036205","article-title":"A randomized, controlled trial of the pan-PPAR Agonist Lanifibranor in NASH","volume":"385","author":"Francque","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.phrs.2023.106925_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.103471","article-title":"Natural products in pursuing novel therapies of nonalcoholic fatty liver disease and steatohepatitis","volume":"28","author":"Li","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.phrs.2023.106925_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154768","article-title":"Therapeutic application of natural products: NAD metabolism as potential target","volume":"114","author":"Guo","year":"2023","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.phrs.2023.106925_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.apsb.2019.11.017","article-title":"Herbal drug discovery for the treatment of nonalcoholic fatty liver disease","volume":"10","author":"Yan","year":"2020","journal-title":"Acta Pharm. Sin. B."},{"issue":"9","key":"10.1016\/j.phrs.2023.106925_bib34","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.freeradbiomed.2012.02.008","article-title":"Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial","volume":"52","author":"Loguercio","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2023.106925_bib35","doi-asserted-by":"crossref","first-page":"3593951","DOI":"10.1155\/2016\/3593951","article-title":"The therapeutic effect of berberine in the treatment of nonalcoholic fatty liver disease: a meta-analysis","volume":"2016","author":"Wei","year":"2016","journal-title":"Evid. Based Complement. Altern. Med."},{"issue":"3","key":"10.1016\/j.phrs.2023.106925_bib36","doi-asserted-by":"crossref","first-page":"169","DOI":"10.5455\/aim.2017.25.169-174","article-title":"Therapeutic effects of curcumin on ultrasonic morphological characteristics of liver in patients with metabolic syndrome","volume":"25","author":"Selmanovic","year":"2017","journal-title":"Acta Inform. Med."},{"issue":"3","key":"10.1016\/j.phrs.2023.106925_bib37","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1053\/j.gastro.2014.12.004","article-title":"Herbal products and the liver: a review of adverse effects and mechanisms","volume":"148","author":"Seeff","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2023.106925_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.nutr.22.111401.144957","article-title":"Dietary flavonoids: bioavailability, metabolic effects, and safety","volume":"22","author":"Ross","year":"2002","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.phrs.2023.106925_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2022.132531","article-title":"Plant flavonoids: classification, distribution, biosynthesis, and antioxidant activity","volume":"383","author":"Shen","year":"2022","journal-title":"Food Chem."},{"issue":"14","key":"10.1016\/j.phrs.2023.106925_bib40","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1080\/10408398.2020.1870035","article-title":"Citrus flavonoids and their antioxidant evaluation","volume":"62","author":"Wang","year":"2022","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.phrs.2023.106925_bib41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0163-7258(02)00298-X","article-title":"The biochemistry and medical significance of the flavonoids","volume":"96","author":"Havsteen","year":"2002","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2023.106925_bib42","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev-nutr-071715-050718","article-title":"Citrus flavonoids as regulators of lipoprotein metabolism and atherosclerosis","volume":"36","author":"Mulvihill","year":"2016","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.phrs.2023.106925_bib43","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.semcancer.2019.08.029","article-title":"Dietary flavonoids: nano delivery and nanoparticles for cancer therapy","volume":"69","author":"Aiello","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.phrs.2023.106925_bib44","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.semcancer.2019.07.023","article-title":"Flavonoids nanoparticles in cancer: treatment, prevention and clinical prospects","volume":"69","author":"Khan","year":"2021","journal-title":"Semin. Cancer Biol."},{"issue":"4","key":"10.1016\/j.phrs.2023.106925_bib45","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3945\/an.113.005603","article-title":"Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action","volume":"5","author":"Alam","year":"2014","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.phrs.2023.106925_bib46","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pharmthera.2018.05.006","article-title":"Clinical benefits and pharmacology of scutellarin: a comprehensive review","volume":"190","author":"Wang","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2023.106925_bib47","first-page":"1354345","article-title":"Scutellarin exerts hypoglycemic and renal protective effects in db\/db Mice via the Nrf2\/HO-1 Signaling Pathway","volume":"2019","author":"Liu","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"issue":"11","key":"10.1016\/j.phrs.2023.106925_bib48","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/s41419-020-03178-2","article-title":"Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-\u03baB\/NLRP3-mediated epithelial-mesenchymal transition and inflammation","volume":"11","author":"Peng","year":"2020","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.phrs.2023.106925_bib49","doi-asserted-by":"crossref","first-page":"18131","DOI":"10.1002\/jcp.28446","article-title":"Scutellarin exerts protective effects against atherosclerosis in rats by regulating the Hippo-FOXO3A and PI3K\/AKT signaling pathways","volume":"234","author":"Fu","year":"2019","journal-title":"J. Cell Physiol."},{"issue":"2","key":"10.1016\/j.phrs.2023.106925_bib50","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1080\/10715762.2017.1422602","article-title":"Scutellarin ameliorates nonalcoholic fatty liver disease through the PPAR\u03b3\/PGC-1\u03b1-Nrf2 pathway","volume":"52","author":"Zhang","year":"2018","journal-title":"Free Radic. Res."},{"issue":"1","key":"10.1016\/j.phrs.2023.106925_bib51","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/ptr.7344","article-title":"Scutellarin ameliorates hepatic lipid accumulation by enhancing autophagy and suppressing IRE1\u03b1\/XBP1 pathway","volume":"36","author":"Zhang","year":"2022","journal-title":"Phytother. Res."},{"issue":"4","key":"10.1016\/j.phrs.2023.106925_bib52","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.orcp.2020.06.005","article-title":"The anti-insulin resistance effect of scutellarin may be related to antioxidant stress and AMPK\u03b1 activation in diabetic mice","volume":"14","author":"Gao","year":"2020","journal-title":"Obes. Res. Clin. Pract."},{"issue":"6","key":"10.1016\/j.phrs.2023.106925_bib53","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/ptr.6582","article-title":"Scutellarin, a modulator of mTOR, attenuates hepatic insulin resistance by regulating hepatocyte lipid metabolism via SREBP-1c suppression","volume":"34","author":"Luan","year":"2020","journal-title":"Phytother. Res."},{"key":"10.1016\/j.phrs.2023.106925_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101095","article-title":"Crosstalk between obesity, diabetes, and alzheimer's disease: Introducing quercetin as an effective triple herbal medicine","volume":"62","author":"Ebrahimpour","year":"2020","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.phrs.2023.106925_bib55","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.fct.2018.02.019","article-title":"Quercetin ameliorates HFD-induced NAFLD by promoting hepatic VLDL assembly and lipophagy via the IRE1a\/XBP1s pathway","volume":"114","author":"Zhu","year":"2018","journal-title":"Food Chem. Toxicol."},{"issue":"15","key":"10.1016\/j.phrs.2023.106925_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202000746","article-title":"Quercetin attenuates atherosclerotic inflammation by inhibiting galectin-3-NLRP3 signaling pathway","volume":"65","author":"Li","year":"2021","journal-title":"Mol. Nutr. Food Res."},{"issue":"10","key":"10.1016\/j.phrs.2023.106925_bib57","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1021\/jf035354z","article-title":"Hypolipidemic effects and absorption of citrus polymethoxylated flavones in hamsters with diet-induced hypercholesterolemia","volume":"52","author":"Kurowska","year":"2004","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.phrs.2023.106925_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2022.108943","article-title":"Tangeretin prevents obesity by modulating systemic inflammation, fat browning, and gut microbiota in high-fat diet-induced obese C57BL\/6 mice","volume":"101","author":"Chen","year":"2022","journal-title":"J. Nutr. Biochem."},{"issue":"20","key":"10.1016\/j.phrs.2023.106925_bib59","doi-asserted-by":"crossref","first-page":"12485","DOI":"10.3390\/ijms232012485","article-title":"The citrus flavonoid nobiletin downregulates angiopoietin-like protein 3 (ANGPTL3) Expression and exhibits lipid-modulating effects in hepatic cells and adult zebrafish models","volume":"23","author":"Lin","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.phrs.2023.106925_bib60","doi-asserted-by":"crossref","first-page":"9853","DOI":"10.3390\/ijms22189853","article-title":"The lipid-modulating effect of tangeretin on the inhibition of angiopoietin-like 3 (ANGPTL3) gene expression through regulation of LXR\u03b1 activation in hepatic cells","volume":"22","author":"Chen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.phrs.2023.106925_bib61","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3390\/ijms20061305","article-title":"The Therapeutic Potential of Apigenin","volume":"20","author":"Salehi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2023.106925_bib62","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bcp.2017.04.014","article-title":"Apigenin, a modulator of PPAR\u03b3, attenuates HFD-induced NAFLD by regulating hepatocyte lipid metabolism and oxidative stress via Nrf2 activation","volume":"136","author":"Feng","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2023.106925_bib63","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.biopha.2018.06.108","article-title":"Apigenin prevents metabolic syndrome in high-fructose diet-fed mice by Keap1-Nrf2 pathway","volume":"105","author":"Yang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2023.106925_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119487","article-title":"Naringin improves lipid metabolism in a tissue-engineered liver model of NAFLD and the underlying mechanisms","volume":"277","author":"Zhang","year":"2021","journal-title":"Life Sci."},{"issue":"20","key":"10.1016\/j.phrs.2023.106925_bib65","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1021\/acs.jafc.1c01109","article-title":"Chrysin Improves Glucose and Lipid Metabolism Disorders by Regulating the AMPK\/PI3K\/AKT Signaling Pathway in Insulin-Resistant HepG2 Cells and HFD\/STZ-Induced C57BL\/6J Mice","volume":"69","author":"Zhou","year":"2021","journal-title":"J. Agric. Food Chem."},{"issue":"5","key":"10.1016\/j.phrs.2023.106925_bib66","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1142\/S0192415X14500724","article-title":"Chrysin and luteolin alleviate vascular complications associated with insulin resistance mainly through PPAR-\u03b3 activation","volume":"42","author":"El-Bassossy","year":"2014","journal-title":"Am. J. Chin. Med."},{"issue":"1","key":"10.1016\/j.phrs.2023.106925_bib67","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbrc.2019.08.139","article-title":"Vitexin alleviates non-alcoholic fatty liver disease by activating AMPK in high fat diet fed mice","volume":"519","author":"Inamdar","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.phrs.2023.106925_bib68","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s12272-017-0992-0","article-title":"\u03b1-Methyl artoflavanocoumarin from Juniperus chinensis exerts anti-diabetic effects by inhibiting PTP1B and activating the PI3K\/Akt signaling pathway in insulin-resistant HepG2 cells","volume":"40","author":"Jung","year":"2017","journal-title":"Arch. Pharm. Res."},{"issue":"1","key":"10.1016\/j.phrs.2023.106925_bib69","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41387-020-00130-3","article-title":"Neohesperidin enhances PGC-1\u03b1-mediated mitochondrial biogenesis and alleviates hepatic steatosis in high fat diet fed mice","volume":"10","author":"Wang","year":"2020","journal-title":"Nutr. Diabetes"},{"issue":"3","key":"10.1016\/j.phrs.2023.106925_bib70","doi-asserted-by":"crossref","first-page":"126","DOI":"10.14712\/fb2021067030126","article-title":"Luteoloside ameliorates palmitic acid-induced in vitro model of non-alcoholic fatty liver disease via activating STAT3-triggered hepatocyte regeneration","volume":"67","author":"Zhu","year":"2021","journal-title":"Folia Biol."},{"issue":"4","key":"10.1016\/j.phrs.2023.106925_bib71","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1507\/endocrj.EJ21-0441","article-title":"Rutin promotes white adipose tissue \"browning\" and brown adipose tissue activation partially through the calmodulin-dependent protein kinase kinase \u03b2\/AMP-activated protein kinase pathway","volume":"69","author":"Ma","year":"2022","journal-title":"Endocr. J."},{"issue":"9","key":"10.1016\/j.phrs.2023.106925_bib72","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1039\/D0FO02736G","article-title":"viaHesperetin ameliorates hepatic oxidative stress and inflammation the PI3K\/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD","volume":"12","author":"Li","year":"2021","journal-title":"Food Funct."},{"key":"10.1016\/j.phrs.2023.106925_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115183","article-title":"Hesperetin protects against palmitate-induced cellular toxicity via induction of GRP78 in hepatocytes","volume":"404","author":"Geng","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.phrs.2023.106925_bib74","doi-asserted-by":"crossref","DOI":"10.1177\/03946320221137435","article-title":"viaLuteolin loaded on zinc oxide nanoparticles ameliorates non-alcoholic fatty liver disease associated with insulin resistance in diabetic rats regulation of PI3K\/AKT\/FoxO1 pathway","volume":"36","author":"Ahmed","year":"2022","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.phrs.2023.106925_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2021.109019","article-title":"Luteolin alleviates non-alcoholic fatty liver disease in rats via restoration of intestinal mucosal barrier damage and microbiota imbalance involving in gut-liver axis","volume":"711","author":"Liu","year":"2021","journal-title":"Arch. Biochem. Biophys."},{"issue":"12","key":"10.1016\/j.phrs.2023.106925_bib76","first-page":"1539","article-title":"Connexin 32 and luteolin play protective roles in non-alcoholic steatohepatitis development and its related hepatocarcinogenesis in rats","volume":"36","author":"Sagawa","year":"2015","journal-title":"Carcinogenesis"},{"issue":"6","key":"10.1016\/j.phrs.2023.106925_bib77","doi-asserted-by":"crossref","first-page":"E1085","DOI":"10.1152\/ajpendo.00034.2021","article-title":"Luteolin alleviates polycystic ovary syndrome in rats by resolving insulin resistance and oxidative stress","volume":"320","author":"Huang","year":"2021","journal-title":"Am. J. Physiol. Endoc. Metabol."},{"issue":"4","key":"10.1016\/j.phrs.2023.106925_bib78","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.bbrc.2016.11.101","article-title":"Luteolin improves non-alcoholic fatty liver disease in db\/db mice by inhibition of liver X receptor activation to down-regulate expression of sterol regulatory element binding protein 1c","volume":"482","author":"Yin","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2023.106925_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117990","article-title":"Combination of luteolin and lycopene effectively protect against the \"two-hit\" in NAFLD through Sirt1\/AMPK signal pathway","volume":"256","author":"Zhu","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2023.106925_bib80","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3389\/fphar.2016.00345","article-title":"Silymarin Ameliorates Metabolic Dysfunction Associated with Diet-Induced Obesity via Activation of Farnesyl X Receptor","volume":"7","author":"Gu","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2023.106925_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2020.108526","article-title":"Nobiletin alleviates high-fat diet-induced nonalcoholic fatty liver disease by modulating AdipoR1 and gp91 expression in rats","volume":"87","author":"Bunbupha","year":"2021","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.phrs.2023.106925_bib82","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bbrc.2022.10.008","article-title":"Nobiletin protects enteric nerves and ameliorates disordered bowel motility in diet-induced obese mice via increasing Trem2 expression","volume":"635","author":"Pang","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2023.106925_bib83","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.metabol.2018.06.007","article-title":"BDNF mimetic alleviates body weight gain in obese mice by enhancing mitochondrial biogenesis in skeletal muscle","volume":"87","author":"Wood","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.phrs.2023.106925_bib84","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbrc.2023.01.090","article-title":"Oroxylin-A alleviates hepatic lipid accumulation and apoptosis under hyperlipidemic conditions via AMPK\/FGF21 signaling","volume":"648","author":"Cho","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2023.106925_bib85","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1080\/13880209.2021.1961823","article-title":"Kaempferol-induced GPER upregulation attenuates atherosclerosis via the PI3K\/AKT\/Nrf2 pathway","volume":"59","author":"Feng","year":"2021","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.phrs.2023.106925_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119133","article-title":"Kaempferide improves glycolipid metabolism disorder by activating PPAR\u03b3 in high-fat-diet-fed mice","volume":"270","author":"Tang","year":"2021","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.phrs.2023.106925_bib87","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.3390\/nu10121962","article-title":"Myricetin exerts anti-obesity effects through upregulation of SIRT3 in adipose tissue","volume":"10","author":"Akindehin","year":"2018","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.phrs.2023.106925_bib88","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/bph.14938","article-title":"Naringenin attenuates non-alcoholic fatty liver disease by down-regulating the NLRP3\/NF-\u03baB pathway in mice","volume":"177","author":"Wang","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2023.106925_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153412","article-title":"Naringenin alleviates nonalcoholic steatohepatitis in middle-aged Apoemice: role of SIRT1","volume":"81","author":"Hua","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phrs.2023.106925_bib90","article-title":"Naringenin attenuates non-alcoholic fatty liver disease by enhancing energy expenditure and regulating autophagy via AMPK","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106925_bib91","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1039\/C9FO02237F","article-title":"Baicalein reduces hepatic fat accumulation by activating AMPK in oleic acid-induced HepG2 cells and high-fat diet-induced non-insulin-resistant mice","volume":"11","author":"Sun","year":"2020","journal-title":"Food Funct."},{"issue":"11","key":"10.1016\/j.phrs.2023.106925_bib92","first-page":"1407","article-title":"AMPK\/PGC-1\u03b1\/GLUT4-mediated effect of icariin on hyperlipidemia-induced non-alcoholic fatty liver disease and lipid metabolism disorder in mice","volume":"86","author":"Lin","year":"2021","journal-title":"Biochemistry"},{"issue":"24","key":"10.1016\/j.phrs.2023.106925_bib93","first-page":"7751","article-title":"Glycyrrhetin improves insulin resistance in HepG2 cells by modulating ERK\/IRS-1 and PI3K\/Akt signaling pathways","volume":"53","author":"Li","year":"2022","journal-title":"Chin. Herb. Med."},{"issue":"11","key":"10.1016\/j.phrs.2023.106925_bib94","first-page":"2444","article-title":"Isoquercetin regulation of PTP1B to improve insulin resistance in network pharmacology and in vitro validation","volume":"37","author":"Liu","year":"2022","journal-title":"Mod. Med. Clin."},{"issue":"1","key":"10.1016\/j.phrs.2023.106925_bib95","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/hep.32221","article-title":"Breviscapine alleviates NASH by inhibiting TGF-\u03b2-activated kinase 1-dependent signaling","volume":"76","author":"Lan","year":"2022","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.phrs.2023.106925_bib96","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1002\/ptr.7101","article-title":"Administration of isoliquiritigenin prevents nonalcoholic fatty liver disease through a novel IQGAP2-CREB-SIRT1 axis","volume":"35","author":"Zhang","year":"2021","journal-title":"Phytother. Res."},{"issue":"2","key":"10.1016\/j.phrs.2023.106925_bib97","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1021\/acs.jafc.0c06652","article-title":"Diosmetin ameliorates nonalcoholic steatohepatitis through modulating lipogenesis and inflammatory response in a STAT1\/CXCL10-dependent manner","volume":"69","author":"Luo","year":"2021","journal-title":"J. Agric. Food Chem."},{"issue":"5","key":"10.1016\/j.phrs.2023.106925_bib98","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1104\/pp.56.5.650","article-title":"Evidence for covalently attached p-coumaric acid and ferulic acid in cutins and suberins","volume":"56","author":"Riley","year":"1975","journal-title":"Plant Physiol."},{"issue":"23","key":"10.1016\/j.phrs.2023.106925_bib99","doi-asserted-by":"crossref","first-page":"15297","DOI":"10.3390\/ijms232315297","article-title":"Ferulic acid and p-coumaric acid synergistically attenuate non-alcoholic fatty liver disease through HDAC1 \/PPARG-mediated free fatty acid uptake","volume":"23","author":"Cui","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2023.106925_bib100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.18632\/aging.100289","article-title":"Reduced mitochondrial function in obesity-associated fatty liver: SIRT3 takes on the fat","volume":"3","author":"Choudhury","year":"2011","journal-title":"Aging"},{"issue":"18","key":"10.1016\/j.phrs.2023.106925_bib101","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1111\/bph.15159","article-title":"Sirtuin 3-mediated deacetylation of acyl-CoA synthetase family member 3 by protocatechuic acid attenuates non-alcoholic fatty liver disease","volume":"177","author":"Sun","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2023.106925_bib102","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3390\/nu13030933","article-title":"The Role of Resveratrol in Liver Disease: A Comprehensive Review from In Vitro to Clinical Trials","volume":"13","author":"Izzo","year":"2021","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.phrs.2023.106925_bib103","doi-asserted-by":"crossref","first-page":"9432","DOI":"10.1039\/D0FO01943G","article-title":"The influence of dietary conditions in the effects of resveratrol on hepatic steatosis","volume":"11","author":"Milton-Laskibar","year":"2020","journal-title":"Food Funct."},{"issue":"3","key":"10.1016\/j.phrs.2023.106925_bib104","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1139\/apnm-2019-0057","article-title":"Resveratrol protects against nonalcoholic fatty liver disease by improving lipid metabolism and redox homeostasis via the PPAR\u03b1 pathway","volume":"45","author":"Huang","year":"2020","journal-title":"Appl. Physiol. Nutr. Metab."},{"issue":"8","key":"10.1016\/j.phrs.2023.106925_bib105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183541","article-title":"Resveratrol and caloric restriction prevent hepatic steatosis by regulating SIRT1-autophagy pathway and alleviating endoplasmic reticulum stress in high-fat diet-fed rats","volume":"12","author":"Ding","year":"2017","journal-title":"PloS One"},{"issue":"8","key":"10.1016\/j.phrs.2023.106925_bib106","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/mnfr.201500016","article-title":"Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway","volume":"59","author":"Zhang","year":"2015","journal-title":"Mol. Nutr. Food Res."},{"issue":"1","key":"10.1016\/j.phrs.2023.106925_bib107","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.taap.2013.04.023","article-title":"Resveratrol inhibits LXR\u03b1-dependent hepatic lipogenesis through novel antioxidant Sestrin2 gene induction","volume":"271","author":"Jin","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"11","key":"10.1016\/j.phrs.2023.106925_bib108","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1007\/s11064-021-03398-8","article-title":"Resveratrol protects SH-SY5Y cells against oleic acid-induced glucolipid metabolic dysfunction and cell injuries via the wnt\/\u03b2-catenin signalling pathway","volume":"46","author":"Xu","year":"2021","journal-title":"Neurochem. Res."},{"issue":"2","key":"10.1016\/j.phrs.2023.106925_bib109","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1124\/jpet.121.001018","article-title":"Resveratrol attenuates high-fat diet-induced hepatic lipotoxicity by upregulating Bmi-1 Expression","volume":"381","author":"Yuan","year":"2022","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"22","key":"10.1016\/j.phrs.2023.106925_bib110","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202100274","article-title":"Curcumin reduces adipose tissue inflammation and alters gut microbiota in diet-induced obese male mice","volume":"65","author":"Islam","year":"2021","journal-title":"Mol. Nutr. Food Res."},{"issue":"5","key":"10.1016\/j.phrs.2023.106925_bib111","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202052146","article-title":"Curcumin prevents obesity by targeting TRAF4-induced ubiquitylation in m A-dependent manner","volume":"22","author":"Chen","year":"2021","journal-title":"EMBO Rep."},{"issue":"31","key":"10.1016\/j.phrs.2023.106925_bib112","doi-asserted-by":"crossref","first-page":"8714","DOI":"10.1021\/acs.jafc.1c03105","article-title":"Regulation on citrate influx and metabolism through inhibiting SLC13A5 and ACLY: a novel mechanism mediating the therapeutic effects of curcumin on NAFLD","volume":"69","author":"Sun","year":"2021","journal-title":"J. Agric. Food Chem."},{"issue":"14","key":"10.1016\/j.phrs.2023.106925_bib113","doi-asserted-by":"crossref","first-page":"6558","DOI":"10.1039\/D1FO00671A","article-title":"Gut microbiota mediates the effects of curcumin on enhancing Ucp1-dependent thermogenesis and improving high-fat diet-induced obesity","volume":"12","author":"Han","year":"2021","journal-title":"Food Funct."},{"issue":"5","key":"10.1016\/j.phrs.2023.106925_bib114","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.apsb.2021.12.014","article-title":"viaAutophagy enhanced by curcumin ameliorates inflammation in atherogenesis the TFEB-P300-BRD4 axis","volume":"12","author":"Li","year":"2022","journal-title":"Acta Pharma. Sin. B"},{"key":"10.1016\/j.phrs.2023.106925_bib115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12933-015-0325-x","article-title":"Polydatin ameliorates lipid and glucose metabolism in type 2 diabetes mellitus by downregulating proprotein convertase subtilisin\/kexin type 9 (PCSK9)","volume":"15","author":"Wang","year":"2016","journal-title":"Cardiovasc. Diabetol."},{"issue":"5","key":"10.1016\/j.phrs.2023.106925_bib116","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1194\/jlr.M013375","article-title":"Anthocyanin inhibits high glucose-induced hepatic mtGPAT1 activation and prevents fatty acid synthesis through PKC\u03b6","volume":"52","author":"Guo","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.phrs.2023.106925_bib117","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.29219\/fnr.v64.1509","article-title":"Purple sweet potato color protects against hepatocyte apoptosis through Sirt1 activation in high-fat-diet-treated mice","volume":"64","author":"Su","year":"2020","journal-title":"Food Nutr. Res."},{"issue":"3","key":"10.1016\/j.phrs.2023.106925_bib118","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3390\/antiox11030472","article-title":"Lingonberry improves hepatic lipid metabolism by targeting Notch1 Signaling","volume":"11","author":"Madduma Hewage","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.phrs.2023.106925_bib119","doi-asserted-by":"crossref","first-page":"8597897","DOI":"10.1155\/2018\/8597897","article-title":"Salidroside attenuates high-fat diet-induced nonalcoholic fatty liver disease via AMPK-Dependent TXNIP\/NLRP3 Pathway","volume":"2018","author":"Zheng","year":"2018","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.phrs.2023.106925_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120949","article-title":"Rhodiola activates macrophage migration inhibitory factor to alleviate non-alcoholic fatty liver disease","volume":"308","author":"Liu","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2023.106925_bib121","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.646489","article-title":"The treatment of rhodiola mimics exercise to resist high-fat diet-induced muscle dysfunction via sirtuin1-dependent mechanisms","volume":"12","author":"You","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2023.106925_bib122","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/ptr.6865","article-title":"Rosmarinic acid exerts an antagonistic effect on nonalcoholic fatty liver disease by regulating the YAP1\/TAZ-PPAR\u03b3\/PGC-1\u03b1 signaling pathway","volume":"35","author":"Luo","year":"2021","journal-title":"Phytother. Res."},{"issue":"4","key":"10.1016\/j.phrs.2023.106925_bib123","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3390\/nu12041166","article-title":"Lemon balm and its constituent, rosmarinic acid, alleviate liver damage in an animal model of nonalcoholic steatohepatitis","volume":"12","author":"Kim","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2023.106925_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107412","article-title":"Epigallocatechin-3-gallate prevents inflammation and diabetes -Induced glucose tolerance through inhibition of NLRP3 inflammasome activation","volume":"93","author":"Zhang","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106925_bib125","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13098-022-00823-y","article-title":"Epigallocatechin-3-gallate ameliorates hepatic damages by relieve FGF21 resistance and promotion of FGF21-AMPK pathway in mice fed a high fat diet","volume":"14","author":"Zhang","year":"2022","journal-title":"Diabetol. Metab. Syndr."},{"issue":"11","key":"10.1016\/j.phrs.2023.106925_bib126","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141227","article-title":"Green tea extract rich in epigallocatechin-3-gallate prevents fatty liver by AMPK Activation via LKB1 in mice fed a high-fat diet","volume":"10","author":"Santamarina","year":"2015","journal-title":"PloS One"},{"issue":"8","key":"10.1016\/j.phrs.2023.106925_bib127","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1142\/S0192415X18500921","article-title":"Polydatin Attenuates Atherosclerosis in ApoE Mice through PBEF mediated reduction of cholesterol deposition","volume":"46","author":"Huang","year":"2018","journal-title":"Am. J. Chin. Med."},{"issue":"1","key":"10.1016\/j.phrs.2023.106925_bib128","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41401-022-00921-7","article-title":"Caffeic acid phenethyl ester suppresses intestinal FXR signaling and ameliorates nonalcoholic fatty liver disease by inhibiting bacterial bile salt hydrolase activity","volume":"44","author":"Zhong","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"issue":"5","key":"10.1016\/j.phrs.2023.106925_bib129","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3390\/antiox11050893","article-title":"Hydroxytyrosol promotes the mitochondrial function through activating mitophagy","volume":"11","author":"Dong","year":"2022","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.phrs.2023.106925_bib130","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3390\/antiox11010092","article-title":"Gallic acid improves diabetic steatosis by downregulating microRNA-34a-5p through Targeting NFE2L2 Expression in High-Fat Diet-Fed db\/db Mice","volume":"11","author":"Lee","year":"2021","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.phrs.2023.106925_bib131","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1096\/fj.201700231RR","article-title":"Vanillic acid attenuates obesity via activation of the AMPK pathway and thermogenic factors in vivo and in vitro","volume":"32","author":"Jung","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2023.106925_bib132","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.693048","article-title":"Chlorogenic acid improves NAFLD by regulating gut microbiota and GLP-1","volume":"12","author":"Shi","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2023.106925_bib133","article-title":"Geniposide and chlorogenic acid combination improves non-alcoholic fatty liver disease involving the potent suppression of elevated hepatic SCD-1","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"15","key":"10.1016\/j.phrs.2023.106925_bib134","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1111\/bph.15083","article-title":"Cyanidin-3-O-glucoside improves non-alcoholic fatty liver disease by promoting PINK1-mediated mitophagy in mice","volume":"177","author":"Li","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2023.106925_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2022.109269","article-title":"Eugenol alleviated nonalcoholic fatty liver disease in rat via a gut-brain-liver axis involving glucagon-like Peptide-1","volume":"725","author":"Li","year":"2022","journal-title":"Arch. Biochem. Biophys."},{"issue":"05","key":"10.1016\/j.phrs.2023.106925_bib136","first-page":"775","article-title":"Lipid-lowering effect of equol on low-density lipoprotein receptor knockout hamsters","volume":"50","author":"Dou","year":"2021","journal-title":"Chin. J. Health Res."},{"issue":"2","key":"10.1016\/j.phrs.2023.106925_bib137","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.taap.2015.02.020","article-title":"Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes","volume":"284","author":"Seo","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.phrs.2023.106925_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154561","article-title":"Pterostilbene alleviated NAFLD via AMPK\/mTOR signaling pathways and autophagy by promoting Nrf2","volume":"109","author":"Shen","year":"2023","journal-title":"Phytomedicine"},{"issue":"04","key":"10.1016\/j.phrs.2023.106925_bib139","first-page":"45","article-title":"Effects of honokiol on insulin resistance in diabetic rats and its mechanism","volume":"37","author":"Jiao","year":"2022","journal-title":"Northwest Pharm. J."},{"key":"10.1016\/j.phrs.2023.106925_bib140","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.plipres.2018.04.004","article-title":"A global perspective on carotenoids: metabolism, biotechnology, and benefits for nutrition and health","volume":"70","author":"Rodriguez-Concepcion","year":"2018","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.phrs.2023.106925_bib141","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.abb.2018.06.001","article-title":"Carotenoids in human nutrition and health","volume":"652","author":"Eggersdorfer","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"issue":"16","key":"10.1016\/j.phrs.2023.106925_bib142","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1111\/bph.15099","article-title":"Astaxanthin attenuates hepatic damage and mitochondrial dysfunction in non-alcoholic fatty liver disease by up-regulating the FGF21\/PGC-1\u03b1 pathway","volume":"177","author":"Wu","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2023.106925_bib143","doi-asserted-by":"crossref","first-page":"1120254","DOI":"10.3389\/fnut.2023.1120254","article-title":"Lycopene prevents non-alcoholic fatty liver disease through regulating hepatic NF-\u03baB\/NLRP3 inflammasome pathway and intestinal microbiota in mice fed with high-fat and high-fructose diet","volume":"10","author":"Gao","year":"2023","journal-title":"Front. Nutr."},{"issue":"8","key":"10.1016\/j.phrs.2023.106925_bib144","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.3390\/nu15081954","article-title":"A review of the effects of fucoxanthin on NAFLD","volume":"15","author":"Sayuti","year":"2023","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.phrs.2023.106925_bib145","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/md20040225","article-title":"Fucoxanthin attenuates free fatty acid-induced nonalcoholic fatty liver disease by regulating lipid metabolism\/oxidative stress\/inflammation via the AMPK\/Nrf2\/ TLR4 signaling pathway","volume":"20","author":"Ye","year":"2022","journal-title":"Mar. Drugs"},{"issue":"4","key":"10.1016\/j.phrs.2023.106925_bib146","article-title":"Zeaxanthin prevents ferroptosis by promoting mitochondrial function and inhibiting the p53 pathway in free fatty acid-induced HepG2 cells","volume":"1868","author":"Liu","year":"2023","journal-title":"Biochim. Biophys. Acta, Mol. Cell Biol. Lipids"},{"issue":"26","key":"10.1016\/j.phrs.2023.106925_bib147","doi-asserted-by":"crossref","first-page":"8061","DOI":"10.3748\/wjg.v21.i26.8061","article-title":"Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats","volume":"21","author":"Qiu","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.phrs.2023.106925_bib148","doi-asserted-by":"crossref","first-page":"9136282","DOI":"10.1155\/2020\/9136282","article-title":"\u03b3Crocin improves insulin sensitivity and ameliorates adiposity by regulating AMPK-CDK5-PPAR signaling","volume":"2020","author":"Fang","year":"2020","journal-title":"BioMed. Res. Int."},{"issue":"5","key":"10.1016\/j.phrs.2023.106925_bib149","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098294","article-title":"\u03b2-Cryptoxanthin alleviates diet-induced nonalcoholic steatohepatitis by suppressing inflammatory gene expression in mice","volume":"9","author":"Kobori","year":"2014","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.phrs.2023.106925_bib150","article-title":"Betulin and its derivatives as novel compounds with different pharmacological effects","volume":"38","author":"Amiri","year":"2020","journal-title":"Biotechnol. Adv."},{"issue":"9","key":"10.1016\/j.phrs.2023.106925_bib151","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.bcp.2013.02.007","article-title":"Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK-mTOR-SREBP signaling pathway","volume":"85","author":"Quan","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106925_bib152","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1038\/s41467-022-31947-4","article-title":"Lactational delivery of Triclosan promotes non-alcoholic fatty liver disease in newborn mice","volume":"13","author":"Weber","year":"2022","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.phrs.2023.106925_bib153","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/bph.14570","article-title":"Betulinic acid alleviates endoplasmic reticulum stress-mediated nonalcoholic fatty liver disease through activation of farnesoid X receptors in mice","volume":"176","author":"Gu","year":"2019","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.phrs.2023.106925_bib154","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.3390\/antiox10081161","article-title":"Ursolic acid and related analogues: triterpenoids with broad health benefits","volume":"10","author":"Nguyen","year":"2021","journal-title":"Antioxidants"},{"issue":"2","key":"10.1016\/j.phrs.2023.106925_bib155","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/mnfr.201400399","article-title":"Ursolic acid improves lipid and glucose metabolism in high-fat-fed C57BL\/6J mice by activating peroxisome proliferator-activated receptor alpha and hepatic autophagy","volume":"59","author":"Jia","year":"2015","journal-title":"Mol. Nutr. Food Res."},{"issue":"8","key":"10.1016\/j.phrs.2023.106925_bib156","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/mnfr.201400670","article-title":"Ursolic acid increases energy expenditure through enhancing free fatty acid uptake and \u03b2-oxidation via an UCP3\/AMPK-dependent pathway in skeletal muscle","volume":"59","author":"Chu","year":"2015","journal-title":"Mol. Nutr. Food Res."},{"issue":"1","key":"10.1016\/j.phrs.2023.106925_bib157","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086724","article-title":"Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats","volume":"9","author":"Li","year":"2014","journal-title":"PloS One"},{"issue":"11","key":"10.1016\/j.phrs.2023.106925_bib158","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1111\/1750-3841.15475","article-title":"Ursolic acid alleviates lipid accumulation by activating the AMPK signaling pathway in vivo and in vitro","volume":"85","author":"Cheng","year":"2020","journal-title":"J. Food Sci."},{"issue":"11","key":"10.1016\/j.phrs.2023.106925_bib159","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1007\/s12031-020-01775-6","article-title":"PGC-1\u0251 Mediated-EXOG, a Specific Repair Enzyme for Mitochondrial DNA, Plays an Essential Role in the Rotenone-Induced Neurotoxicity of PC12 Cells","volume":"71","author":"Xiao","year":"2021","journal-title":"J. Mol. Neurosci."},{"issue":"4","key":"10.1016\/j.phrs.2023.106925_bib160","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.cmet.2015.08.005","article-title":"Celastrol Protects against Obesity and Metabolic Dysfunction through Activation of a HSF1-PGC1\u03b1 Transcriptional Axis","volume":"22","author":"Ma","year":"2015","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.phrs.2023.106925_bib161","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.phymed.2015.12.018","article-title":"Corosolic acid inhibits adipose tissue inflammation and ameliorates insulin resistance via AMPK activation in high-fat fed mice","volume":"23","author":"Yang","year":"2016","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.phrs.2023.106925_bib162","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.bbrc.2012.12.066","article-title":"Tanshinone IIA improves endoplasmic reticulum stress-induced insulin resistance through AMP-activated protein kinase","volume":"430","author":"Hwang","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.phrs.2023.106925_bib163","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.bbrc.2009.10.162","article-title":"Bixin regulates mRNA expression involved in adipogenesis and enhances insulin sensitivity in 3T3-L1 adipocytes through PPARgamma activation","volume":"390","author":"Takahashi","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2023.106925_bib164","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.phrs.2017.12.026","article-title":"Catalpol ameliorates hepatic insulin resistance in type 2 diabetes through acting on AMPK\/NOX4\/ PI3K\/AKT pathway","volume":"130","author":"Yan","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.phrs.2023.106925_bib165","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/abbs\/gmaa157","article-title":"Geniposide improves insulin resistance through AMPK-mediated Txnip protein degradation in 3T3-L1 adipocytes","volume":"53","author":"Zhao","year":"2021","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"9","key":"10.1016\/j.phrs.2023.106925_bib166","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.phymed.2015.05.058","article-title":"Two triterpeniods from Cyclocarya paliurus (Batal) Iljinsk (Juglandaceae) promote glucose uptake in 3T3-L1 adipocytes: The relationship to AMPK activation","volume":"22","author":"Zhu","year":"2015","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.phrs.2023.106925_bib167","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.bbrc.2010.05.034","article-title":"Ascofuranone prevents ER stress-induced insulin resistance via activation of AMP-activated protein kinase in L6 myotube cells","volume":"396","author":"Hwang","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2023.106925_bib168","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.phrs.2017.04.021","article-title":"Cycloastragenol improves hepatic steatosis by activating farnesoid X receptor signalling","volume":"121","author":"Gu","year":"2017","journal-title":"Pharmacol. Res."},{"issue":"10","key":"10.1016\/j.phrs.2023.106925_bib169","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.cmet.2022.09.007","article-title":"Late isocaloric eating increases hunger, decreases energy expenditure, and modifies metabolic pathways in adults with overweight and obesity","volume":"34","author":"Vujovi\u0107","year":"2022","journal-title":"Cell Metab."},{"issue":"14","key":"10.1016\/j.phrs.2023.106925_bib170","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1021\/acs.jafc.0c00833","article-title":"Ginsenoside Rg2 Ameliorates High-Fat Diet-Induced Metabolic Disease through SIRT1","volume":"68","author":"Cheng","year":"2020","journal-title":"J. Agric. Food Chem."},{"issue":"1","key":"10.1016\/j.phrs.2023.106925_bib171","article-title":"Tianhuang formula reduces the oxidative stress response of NAFLD by regulating the gut microbiome in mice","volume":"13","author":"Luo","year":"2022","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.phrs.2023.106925_bib172","first-page":"73","article-title":"Ginsenoside Re lowers blood glucose and lipid levels via activation of AMP-activated protein kinase in HepG2 cells and high-fat diet fed mice","volume":"29","author":"Quan","year":"2012","journal-title":"Int. Mol. Med."},{"issue":"1","key":"10.1016\/j.phrs.2023.106925_bib173","article-title":"HCBP6 deficiency exacerbates glucose and lipid metabolism disorders in non-alcoholic fatty liver mice","volume":"129","author":"Lu","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.phrs.2023.106925_bib174","doi-asserted-by":"crossref","first-page":"11784","DOI":"10.1080\/21655979.2021.1996508","article-title":"Synergetic protective effect of berberine and ginsenoside Rb1 against tumor necrosis factor alpha-induced inflammation in adipocytes","volume":"12","author":"Cai","year":"2021","journal-title":"Bioengineered"},{"issue":"2","key":"10.1016\/j.phrs.2023.106925_bib175","article-title":"Ginsenoside Rb1 alleviated high-fat-diet-induced hepatocytic apoptosis via peroxisome proliferator-activated receptor","volume":"2020","author":"Song","year":"2020","journal-title":"BioMed. Res. Int."},{"issue":"5","key":"10.1016\/j.phrs.2023.106925_bib176","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1039\/C9FO00095J","article-title":"Ginsenoside Rk3 ameliorates high-fat-diet\/streptozocin induced type 2 diabetes mellitus in mice via the AMPK\/Akt signaling pathway","volume":"10","author":"Liu","year":"2019","journal-title":"Food Funct."},{"issue":"10","key":"10.1016\/j.phrs.2023.106925_bib177","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.3390\/antiox11101890","article-title":"Ginsenoside CK Inhibits the Early Stage of Adipogenesis via the AMPK, MAPK, and AKT Signaling Pathways","volume":"11","author":"Oh","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.phrs.2023.106925_bib178","series-title":"The lipid-lowering effect of ginsenoside CK on enhancing lipophagy and lipase ATGL expression","author":"Yang","year":"2022"},{"issue":"4","key":"10.1016\/j.phrs.2023.106925_bib179","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/ptr.7413","article-title":"A novel natural PPAR\u03b3 agonist, Gypenoside LXXV, ameliorates cognitive deficits by enhancing brain glucose uptake via the activation of Akt\/GLUT4 signaling in db\/db mice","volume":"36","author":"Meng","year":"2022","journal-title":"Phytother. Res."},{"issue":"7","key":"10.1016\/j.phrs.2023.106925_bib180","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/jphp.12392","article-title":"Chikusetsu saponin IVa regulates glucose uptake and fatty acid oxidation: implications in antihyperglycemic and hypolipidemic effects","volume":"67","author":"Li","year":"2015","journal-title":"J. Pharm. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2023.106925_bib181","article-title":"Astragaloside IV inhibits protein tyrosine phosphatase 1B and improves insulin resistance in insulin-resistant HepG2 cells and triglyceride accumulation in oleic acid (OA)-treated HepG2 cells","volume":"268","author":"Zhou","year":"2021","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2023.106925_bib182","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.phrs.2018.03.017","article-title":"Dioscin alleviates non-alcoholic fatty liver disease through adjusting lipid metabolism via SIRT1\/AMPK signaling pathway","volume":"131","author":"Yao","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2023.106925_bib183","series-title":"Study on the Hypoglycemic Effect and Mechanism of Ginsenoside Rk3\/Rh4","author":"Yao","year":"2021"},{"key":"10.1016\/j.phrs.2023.106925_bib184","series-title":"Pharmacodynamics and Mechanism of Ginsenoside Ro in Improving Obesity and its Metabolic Complications","author":"Jiang","year":"2019"},{"key":"10.1016\/j.phrs.2023.106925_bib185","series-title":"Study on the mechanism of ginsenoside Rg3 improving insulin resistance in obesity and preparation of its solid dispersion","author":"Xu","year":"2022"},{"key":"10.1016\/j.phrs.2023.106925_bib186","series-title":"The mechanism of ginsenoside Rg3 protecting islet \u03b2 cells by enhancing the function of autolysosome","author":"Pan","year":"2021"},{"issue":"1","key":"10.1016\/j.phrs.2023.106925_bib187","article-title":"Berberine: a review of its pharmacokinetics properties and therapeutic potentials in diverse vascular diseases","volume":"12","author":"Ai","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2023.106925_bib188","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/13543776.2021.1974001","article-title":"A patent review of berberine and its derivatives with various pharmacological activities (2016-2020)","volume":"32","author":"Kong","year":"2022","journal-title":"Expert Opin. Ther. Pat."},{"issue":"2","key":"10.1016\/j.phrs.2023.106925_bib189","first-page":"12","article-title":"Berberine: Pharmacological features in health, disease and aging","volume":"4","author":"Gasmi","year":"2023","journal-title":"Curr. Med. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2023.106925_bib190","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3390\/molecules28031294","article-title":"Fibraurea tinctoriaA review of and its component, berberine, as an antidiabetic and antioxidant","volume":"28","author":"Purwaningsih","year":"2023","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.phrs.2023.106925_bib191","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.joim.2021.09.003","article-title":"Berberine mitigates nonalcoholic hepatic steatosis by downregulating SIRT1-FoxO1-SREBP2 pathway for cholesterol synthesis","volume":"19","author":"Shan","year":"2021","journal-title":"J. Integr. Med."},{"issue":"6","key":"10.1016\/j.phrs.2023.106925_bib192","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.mito.2013.09.002","article-title":"Berberine reverts hepatic mitochondrial dysfunction in high-fat fed rats: a possible role for SirT3 activation","volume":"13","author":"Teodoro","year":"2013","journal-title":"Mitochondrion"},{"issue":"7285","key":"10.1016\/j.phrs.2023.106925_bib193","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nature08778","article-title":"SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation","volume":"464","author":"Hirschey","year":"2010","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.phrs.2023.106925_bib194","doi-asserted-by":"crossref","first-page":"7289","DOI":"10.1096\/fj.201802316R","article-title":"Berberine alleviates nonalcoholic fatty liver induced by a high-fat diet in mice by activating SIRT3","volume":"33","author":"Xu","year":"2019","journal-title":"FASEB J."},{"issue":"9","key":"10.1016\/j.phrs.2023.106925_bib195","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1194\/jlr.M001958","article-title":"Berberine reduces methylation of the MTTP promoter and alleviates fatty liver induced by a high-fat diet in rats","volume":"51","author":"Chang","year":"2010","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.phrs.2023.106925_bib196","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/14728222.2020.1728742","article-title":"Emerging therapeutic targets for NASH: key innovations at the preclinical level","volume":"24","author":"Horn","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"issue":"2","key":"10.1016\/j.phrs.2023.106925_bib197","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fphar.2020.00185","article-title":"viaBerberine Inhibits Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome Activation and Pyroptosis in Nonalcoholic Steatohepatitis the ROS\/TXNIP Axis","volume":"11","author":"Mai","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2023.106925_bib198","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.biopha.2018.05.110","article-title":"Berberine alleviates adipose tissue fibrosis by inducing AMP-activated kinase signaling in high-fat diet-induced obese mice","volume":"105","author":"Wang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2023.106925_bib199","doi-asserted-by":"crossref","first-page":"33102","DOI":"10.1038\/srep33102","article-title":"Pentoxifylline ameliorates non-alcoholic fatty liver disease in hyperglycaemic and dyslipidaemic mice by upregulating fatty acid \u03b2-oxidation","volume":"6","author":"Ye","year":"2016","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.phrs.2023.106925_bib200","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s12072-015-9633-1","article-title":"Comparative clinical study between the effect of fenofibrate alone and its combination with pentoxifylline on biochemical parameters and liver stiffness in patients with non-alcoholic fatty liver disease","volume":"9","author":"El-Haggar","year":"2015","journal-title":"Hepatol. Int."},{"issue":"24","key":"10.1016\/j.phrs.2023.106925_bib201","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.4254\/wjh.v7.i24.2551","article-title":"Role of pentoxifylline in non-alcoholic fatty liver disease in high-fat diet-induced obesity in mice","volume":"7","author":"Acedo","year":"2015","journal-title":"World J. Hepatol."},{"issue":"4","key":"10.1016\/j.phrs.2023.106925_bib202","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/hep.25778","article-title":"Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: new evidence on the potential therapeutic mechanism","volume":"56","author":"Zein","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2023.106925_bib203","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154368","article-title":"Pentoxifylline attenuates nonalcoholic fatty liver by inhibiting hepatic macrophage polarization to the M1 phenotype","volume":"106","author":"Xu","year":"2022","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.phrs.2023.106925_bib204","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s12967-018-1685-2","article-title":"Matrine attenuates endoplasmic reticulum stress and mitochondrion dysfunction in nonalcoholic fatty liver disease by regulating SERCA pathway","volume":"16","author":"Gao","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.phrs.2023.106925_bib205","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105917","article-title":"Hirsutine ameliorates hepatic and cardiac insulin resistance in high-fat diet-induced diabetic mice and in vitro models","volume":"177","author":"Hu","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2023.106925_bib206","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173557","article-title":"Eurocristatine, a plant alkaloid from Eurotium cristatum, alleviates insulin resistance in db\/db diabetic mice via activation of PI3K\/AKT signaling pathway","volume":"887","author":"Zhang","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106925_bib207","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1080\/13880209.2021.1945112","article-title":"Esculin protects against methionine choline-deficient diet-induced non-alcoholic steatohepatitis by regulating the Sirt1\/NF-B p65 pathway","volume":"59","author":"Yang","year":"2021","journal-title":"Pharm. Biol."},{"issue":"22","key":"10.1016\/j.phrs.2023.106925_bib208","doi-asserted-by":"crossref","first-page":"14108","DOI":"10.3390\/ijms232214108","article-title":"Quinones as an efficient molecular scaffold in the antibacterial\/antifungal or antitumoral arsenal","volume":"23","author":"Dahlem Junior","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2023.106925_bib209","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/antiox11020343","article-title":"Antioxidant activity of natural hydroquinones","volume":"11","author":"Giner","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.phrs.2023.106925_bib210","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2147\/DDDT.S243893","article-title":"Radix polygoni multiflori and its main component emodin attenuate non-alcoholic fatty liver disease in zebrafish by regulation of AMPK signaling pathway","volume":"14","author":"Yu","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.phrs.2023.106925_bib211","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114340","article-title":"Emodin palliates high-fat diet-induced nonalcoholic fatty liver disease in mice via activating the farnesoid X receptor pathway","volume":"279","author":"Shen","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2023.106925_bib212","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110002","article-title":"The pharmacological properties of chrysophanol, the recent advances","volume":"125","author":"Su","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2023.106925_bib213","doi-asserted-by":"crossref","first-page":"7374086","DOI":"10.1155\/2020\/7374086","article-title":"Chrysophanol alleviates metabolic syndrome by activating the SIRT6\/AMPK signaling pathway in brown adipocytes","volume":"2020","author":"Liu","year":"2020","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.phrs.2023.106925_bib214","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.biopha.2018.12.019","article-title":"Sodium tanshinone IIA sulfonate ameliorates hepatic steatosis by inhibiting lipogenesis and inflammation","volume":"111","author":"Li","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.phrs.2023.106925_bib215","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3390\/biomedicines9030326","article-title":"Tanshinone IIA downregulates lipogenic gene expression and attenuates lipid accumulation through the modulation of LXR\u03b1\/SREBP1 pathway in HepG2 Cells","volume":"9","author":"Gao","year":"2021","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.phrs.2023.106925_bib216","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/ptr.7662","article-title":"Thymoquinone attenuates hepatic lipid accumulation by inducing autophagy via AMPK\/mTOR\/ULK1-dependent pathway in nonalcoholic fatty liver disease","volume":"37","author":"Zhang","year":"2022","journal-title":"Phytother. Res."},{"issue":"23","key":"10.1016\/j.phrs.2023.106925_bib217","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.3748\/wjg.v23.i23.4146","article-title":"Antioxidant dietary approach in treatment of fatty liver: New insights and updates","volume":"23","author":"Ferramosca","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.phrs.2023.106925_bib218","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118615","article-title":"The mother relationship between insulin resistance and non-alcoholic steatohepatitis: Glucosinolates hydrolysis products as a promising insulin resistance-modulator and fatty liver-preventer","volume":"264","author":"Mohammed","year":"2021","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.phrs.2023.106925_bib219","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.2337\/db16-0662","article-title":"Glucoraphanin ameliorates obesity and insulin resistance through adipose tissue browning and reduction of metabolic endotoxemia in mice","volume":"66","author":"Nagata","year":"2017","journal-title":"Diabetes"},{"issue":"44","key":"10.1016\/j.phrs.2023.106925_bib220","doi-asserted-by":"crossref","first-page":"13066","DOI":"10.1021\/acs.jafc.1c04933","article-title":"Sulforaphane regulates glucose and lipid metabolisms in obese mice by restraining jnk and activating insulin and FGF21 signal pathways","volume":"69","author":"Tian","year":"2021","journal-title":"J. Agric. Food Chem."},{"issue":"34","key":"10.1016\/j.phrs.2023.106925_bib221","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.3748\/wjg.v25.i34.5120","article-title":"viaAllyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease the Sirt1\/AMPK and NF-\u03baB signaling pathways","volume":"25","author":"Li","year":"2019","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.phrs.2023.106925_bib222","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.jhep.2014.12.034","article-title":"Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity","volume":"62","author":"Mueller","year":"2015","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.phrs.2023.106925_bib223","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.bbrc.2020.05.128","article-title":"Ursodeoxycholic acid alleviates nonalcoholic fatty liver disease by inhibiting apoptosis and improving autophagy via activating AMPK","volume":"529","author":"Wu","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.phrs.2023.106925_bib224","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.bbalip.2019.07.006","article-title":"Ursodeoxycholic acid is a GPBAR1 agonist and resets liver\/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH","volume":"1864","author":"Carino","year":"2019","journal-title":"Biochim. Biophys. Acta, Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.phrs.2023.106925_bib225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174760","article-title":"Ursodesoxycholic acid is an FFA4 agonist and reduces hepatic steatosis via FFA4 signaling","volume":"917","author":"Xu","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.phrs.2023.106925_bib226","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.jnutbio.2012.12.006","article-title":"S-allyl cysteine attenuates free fatty acid-induced lipogenesis in human HepG2 cells through activation of the AMP-activated protein kinase-dependent pathway","volume":"24","author":"Hwang","year":"2013","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.phrs.2023.106925_bib227","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113367","article-title":"The methyltransferase METTL3-mediated fatty acid metabolism revealed the mechanism of cinnamaldehyde on alleviating steatosis","volume":"153","author":"Xu","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"10.1016\/j.phrs.2023.106925_bib228","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.nut.2007.07.003","article-title":"Alpha-linolenic acid attenuates high glucose-induced apoptosis in cultured human umbilical vein endothelial cells via PI3K\/Akt\/eNOS pathway","volume":"23","author":"Zhang","year":"2007","journal-title":"Nutrition"},{"issue":"7","key":"10.1016\/j.phrs.2023.106925_bib229","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1021\/acs.jnatprod.2c00259","article-title":"Xyloketal B reverses nutritional hepatic steatosis, steatohepatitis, and liver fibrosis through activation of the PPAR\u03b1\/PGC1\u03b1 signaling pathway","volume":"85","author":"Tong","year":"2022","journal-title":"J. Nat. Prod."},{"issue":"6","key":"10.1016\/j.phrs.2023.106925_bib230","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.3390\/nu13061950","article-title":"Matcha green tea alleviates non-alcoholic fatty liver disease in high-fat diet-induced obese mice by regulating lipid metabolism and inflammatory responses","volume":"13","author":"Zhou","year":"2021","journal-title":"Nutrients"},{"issue":"17","key":"10.1016\/j.phrs.2023.106925_bib231","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1002\/elps.201500076","article-title":"Comparative proteomic analysis using 2DE-LC-MS\/MS reveals the mechanism of Fuzhuan brick tea extract against hepatic fat accumulation in rats with nonalcoholic fatty liver disease","volume":"36","author":"Liu","year":"2015","journal-title":"Electrophoresis"},{"issue":"2","key":"10.1016\/j.phrs.2023.106925_bib232","first-page":"96","article-title":"Gallic acid ameliorated impaired glucose and lipid homeostasis in high fat diet-induced NAFLD mice","volume":"9","author":"Chao","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.phrs.2023.106925_bib233","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104519","article-title":"Combinational applicaton of silybin and tangeretin attenuates the progression of non-alcoholic steatohepatitis (NASH) in mice via modulating lipid metabolism","volume":"151","author":"Suguro","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"36","key":"10.1016\/j.phrs.2023.106925_bib234","doi-asserted-by":"crossref","first-page":"11224","DOI":"10.1021\/acs.jafc.2c02334","article-title":"Effect of hesperidin supplementation on liver metabolomics and gut microbiota in a high-fat diet-induced NAFLD mice model","volume":"70","author":"Li","year":"2022","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.phrs.2023.106925_bib235","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12967-016-0982-x","article-title":"Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease","volume":"14","author":"Chang","year":"2016","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.phrs.2023.106925_bib236","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119778","article-title":"Demethylenetetra-hydroberberine alleviates nonalcoholic fatty liver disease by inhibiting the NLRP3 inflammasome and oxidative stress in mice","volume":"281","author":"Zhang","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2023.106925_bib237","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115680","article-title":"Uncovering the effect and mechanism of Panax notoginseng saponins on metabolic syndrome by network pharmacology strategy","volume":"300","author":"Wang","year":"2023","journal-title":"J. Ethnopharmacol."},{"issue":"8","key":"10.1016\/j.phrs.2023.106925_bib238","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.tips.2019.06.004","article-title":"Advancing drug discovery via artificial intelligence","volume":"40","author":"Chan","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2023.106925_bib239","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1080\/09168451.2017.1387515","article-title":"Suppressive effect of nobiletin and epicatechin gallate on fructose uptake in human intestinal epithelial Caco-2 cells","volume":"82","author":"Satsu","year":"2018","journal-title":"Biosci. Biotechnol. Biochem."},{"issue":"9","key":"10.1016\/j.phrs.2023.106925_bib240","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.3390\/ijms19092555","article-title":"Penthorum chinenseFlavonones from Ameliorate Hepatic Steatosis by Activating the SIRT1\/AMPK Pathway in HepG2 Cells","volume":"19","author":"Guo","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2023.106925_bib241","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154589","article-title":"Phytochemical gallic acid alleviates nonalcoholic fatty liver disease via AMPK-ACC-PPARa axis through dual regulation of lipid metabolism and mitochondrial function","volume":"109","author":"Zhang","year":"2023","journal-title":"Phytomedicine"},{"issue":"6","key":"10.1016\/j.phrs.2023.106925_bib242","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/j.apsb.2021.12.023","article-title":"Gentiopicroside targets PAQR3 to activate the PI3K\/AKT signaling pathway and ameliorate disordered glucose and lipid metabolism","volume":"12","author":"Xiao","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phrs.2023.106925_bib243","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154634","article-title":"Celastrol targets the ChREBP-TXNIP axis to ameliorates type 2 diabetes mellitus","volume":"110","author":"Zhou","year":"2023","journal-title":"Phytomedicine"},{"issue":"6","key":"10.1016\/j.phrs.2023.106925_bib244","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1007\/s00213-020-05502-2","article-title":"7,8-Dihydroxyflavone alleviated the high-fat diet and alcohol-induced memory impairment: behavioral, biochemical and molecular evidence","volume":"237","author":"Pandey","year":"2020","journal-title":"Psychopharma-cology"},{"key":"10.1016\/j.phrs.2023.106925_bib245","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101149","article-title":"Crosstalk between the muscular estrogen receptor \u03b1 and BDNF\/TrkB signaling alleviates metabolic syndrome via 7,8-dihydroxyflavone in female mice","volume":"45","author":"Zhao","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.phrs.2023.106925_bib246","series-title":"Ameliorative Effect of Curcumin on BPA-Induced Insulin Resistance in Human Hepatocyte L02 Cells and its Mechanism","first-page":"412","author":"Geng","year":"2019"},{"key":"10.1016\/j.phrs.2023.106925_bib247","series-title":"The mechanism of Ginsenoside Rg2 Promoting SIRT1 to Improve non-Alcoholic Fatty Liver Disease","author":"Cheng","year":"2021"},{"key":"10.1016\/j.phrs.2023.106925_bib248","series-title":"The Mechanism of Ginsenoside Rb1 Upregulating Adiponectin to Improve Liver Steatosis","author":"Li","year":"2022"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823002815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823002815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:49:05Z","timestamp":1760914145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661823002815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":248,"alternative-id":["S1043661823002815"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106925","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural products in non-alcoholic fatty liver disease (NAFLD): Novel lead discovery for drug development","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106925","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106925"}}